Gruvin said:

---

cinque said:

---

Gruvin said:

---

cinque said:

---

Gruvin said:

---

cinque said:

---

---

lol...

---

There's nothing funny about people dying from COVID. Texas' positivity rate is 20%. That's not funny either.

---

lol- learn science... then come talk to me

That twit post is garbage journalism with cherry picked details to elicit an emotional response.

Texas current positivity rate is 11.6%

---

Yeah. Science. https://abc13.com/health/covid-19-testing-positivity-rate-hits-new-high-in-texas/6363998/

---

as usual, you Are adding nothing to the discussion. The communication problem with what i am saying and what Sam was saying has been worked out. I dont agree with the importance of it, especially since total positives per day is going down in TX but whatever

---

The importance is related to the question you asked earlier. Because the positivity rate is a percentage, it may increase even as total positives per day decrease. When that happens, it's a sign that the actual number of new cases per day is still increasing but we aren't doing enough testing to be able to track it.

Sam Lowry said:

---

Gruvin said:

---

cinque said:

---

Gruvin said:

---

cinque said:

---

Gruvin said:

---

cinque said:

---

---

lol...

---

There's nothing funny about people dying from COVID. Texas' positivity rate is 20%. That's not funny either.

---

lol- learn science... then come talk to me

That twit post is garbage journalism with cherry picked details to elicit an emotional response.

Texas current positivity rate is 11.6%

---

Yeah. Science. https://abc13.com/health/covid-19-testing-positivity-rate-hits-new-high-in-texas/6363998/

---

as usual, you Are adding nothing to the discussion. The communication problem with what i am saying and what Sam was saying has been worked out. I dont agree with the importance of it, especially since total positives per day is going down in TX but whatever

---

The importance is related to the question you asked earlier. Because the positivity rate is a percentage, it may increase even as total positives per day decrease. When that happens, it's a sign that the actual number of new cases per day is still increasing but we aren't doing enough testing to be able to track it.

---

that is a very plausible hypothesis. If it holds true, we should see another spike soon from the asymptomatic /untested causing new cases

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

That's right, and that's what was always going to happen and is happening everywhere, affected by various factors such as density, population health, etc. All we can do is affect timing a bit.

July 4 Total 1,308 | COVID 568 | 7 Day Avg. Growth Rate for ICU 4.3%
July 5 Total 1,307 | COVID 589 | 7 Day Avg. Growth Rate for ICU 4.3%
July 6 Total 1,362 | COVID 600 | 7 Day Avg. Growth Rate for ICU 4.0%
July 7 Total 1,364 | COVID 615 | 7 Day Avg. Growth Rate for ICU 3.7%
July 8 Total 1,394 | COVID 626 | 7 Day Avg. Growth Rate for ICU 3.3%
July 9 Total 1,394 | COVID 646 | 7 Day Avg. Growth Rate for ICU 3.2%
July 10 Total 1,420 | COVID 651 | 7 Day Avg. Growth Rate for ICU 3.0%
July 11 Total 1,368 | COVID 646 | 7 Day Avg. Growth Rate for ICU 2.3%
July 12 Total 1,365 | COVID 682 | 7 Day Avg. Growth Rate for ICU 2.0%
July 13 Total 1,352 | COVID 674 | 7 Day Avg. Growth Rate for ICU 1.9%
July 14 Total 1.359 | COVID 676 | 7 Day Avg. Growth Rate for ICU 1.5%
July 15 Total 1.400 | COVID 678 | 7 Day Avg. Growth Rate for ICU 1.3%
July 16 Total 1.400 | COVID 689 | 7 Day Avg. Growth Rate for ICU 1.0%
July 17 Total 1.381 | COVID 700 | 7 Day Avg. Growth Rate for ICU 1.0%
July 17 Total 1.381 | COVID 700 | 7 Day Avg. Growth Rate for ICU 1.0%
July 18 Total 1.345 | COVID 667 | 7 Day Avg. Growth Rate for ICU 0.8%
July 19 Total 1.361 | COVID 664 | 7 Day Avg. Growth Rate for ICU 0.0%
July 20 Total 1.347 | COVID 686 | 7 Day Avg. Growth Rate for ICU 0.0%
July 21 Total 1.386 | COVID 691 | 7 Day Avg. Growth Rate for ICU 0.3%
July 22 Total 1.431 | COVID 716 | 7 Day Avg. Growth Rate for ICU 0.6%
July 23 Total 1.456 | COVID 714 | 7 Day Avg. Growth Rate for ICU 0.7% | 7 Day Avg. Growth Rate COVID hosp admits -0.4%
July 24 Total 1.422 | COVID 681 | 7 Day Avg. Growth Rate for ICU 0.1% | 7 Day Avg. Growth Rate COVID hosp admits -1.5%
July 25 Total 1.416 | COVID 691 | 7 Day Avg. Growth Rate for ICU 0.1% | 7 Day Avg. Growth Rate COVID hosp admits -1.5%
July 26 Total 1.408 | COVID 682 | 7 Day Avg. Growth Rate for ICU 0.5% | 7 Day Avg. Growth Rate COVID hosp admits -2.5%
July 27 Total 1,373 | COVID 677 | 7 Day Avg. Growth Rate for ICU 0.1% | 7 Day Avg. Growth Rate COVID hosp admits -2.8%
July 28 Total 1,387 | COVID 650 | 7 Day Avg. Growth Rate for ICU -0.5% | 7 Day Avg. Growth Rate COVID hosp admits -3.0%
July 29 Total 1,426 | COVID 625 | 7 Day Avg. Growth Rate for ICU -1.4% | 7 Day Avg. Growth Rate COVID hosp admits -3.0%
July 30 Total 1,435 | COVID 639 | 7 Day Avg. Growth Rate for ICU -1.7% | 7 Day Avg. Growth Rate COVID hosp admits -3.5%
July 31 Total 1,388 | COVID 632 | 7 Day Avg. Growth Rate for ICU -1.3% | 7 Day Avg. Growth Rate COVID hosp admits -3.9%
AUG. 1 Total 1,330 | COVID 617 | 7 Day Avg. Growth Rate for ICU -1.3% | 7 Day Avg. Growth Rate COVID hosp admits -5.0%
AUG. 2 Total 1,324 | COVID 569 | 7 Day Avg. Growth Rate for ICU -2.0% | 7 Day Avg. Growth Rate COVID hosp admits -3.8%
AUG. 3 Total 1,315 | COVID 568 | 7 Day Avg. Growth Rate for ICU -2.5% | 7 Day Avg. Growth Rate COVID hosp admits 0.1%
AUG. 4 Total 1,375 | COVID 570 | 7 Day Avg. Growth Rate for ICU -2.2% | 7 Day Avg. Growth Rate COVID hosp admits -0.2%
AUG. 5 Total 1,364 | COVID 542 | 7 Day Avg. Growth Rate for ICU -1.9% | 7 Day Avg. Growth Rate COVID hosp admits -2.1%
AUG. 6 Total 1,349 | COVID 512 | 7 Day Avg. Growth Rate for ICU -2.5% | 7 Day Avg. Growth Rate COVID hosp admits -4.2%
AUG. 7 Total 1,396 | COVID 510 | 7 Day Avg. Growth Rate for ICU -3.1% | 7 Day Avg. Growth Rate COVID hosp admits -2.7%
AUG. 8 Total 1,392 | COVID 501 | 7 Day Avg. Growth Rate for ICU -3.0% | 7 Day Avg. Growth Rate COVID hosp admits 0.4%
AUG. 9 Total 1,330 | COVID 477 | 7 Day Avg. Growth Rate for ICU -2.2% | 7 Day Avg. Growth Rate COVID hosp admits -4.7%

https://www.tmc.edu/coronavirus-updates/

Houston Methodist "COVID-19 Cases by Day". Click scroll to 2nd chart.
https://www.houstonmethodist.org/-/media/pdf/for-patients/Coronavirus/covid-19-stats.ashx

Death rates from coronavirus (COVID-19) in the United States (per 100,000 people)
https://www.statista.com/statistics/1109011/coronavirus-covid19-death-rates-us-by-state/
-- 08 07 2020 --
NJ 179
NY 168
FL 38
TX 32
CA 26

Total number of cases of coronavirus (COVID-19) in the United States by state
https://www.statista.com/statistics/1102807/coronavirus-covid19-cases-number-us-americans-by-state/
CA 561k (39.5M population)
FL 532k (21.4M)
TX 503k (29M)
NY 420k (19.4M)
GA 216k (10.6M)

Daily confirmed COVID-19 cases and deaths, United States
https://ourworldindata.org/grapher/daily-covid-cases-deaths?time=2020-01-25..&country=~USA

CDC Pneumonia Deaths and COVID-19 Deaths since 2/1/2020. Click for age group breakdown. Pneumonia more deadly for the young <24 years old, then it begins to even out.
https://data.cdc.gov/NCHS/Provisional-COVID-19-Death-Counts-by-Sex-Age-and-S/9bhg-hcku

COVID-19 Deaths 142,164
Pneumonia Deaths 150,095

Doc Holliday said:

---

I don't think many of you are willing to admit how disgusting and corrupt humanity can be. How bad things can get when it comes to money and exploiting problems. Y'all just live in your little bubbles where you think honor and integrity are rampant.

---

^^^ The Baylor bubble? There's a lot of hard working Baylor people I know that paid all or most of their education but then there's plenty that have it given to em. And that was long before Obama's liberal student loan scam too. Now you're describing that crowd too

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

This may be splitting hairs but IMHO we are not in full on burn through. Some states like CA remain fairly locked down while others like Florida and Georgia are more open and may be closer to full on burn mode. although hey retain some lockdown rules. Most are taking additional steps trying to protect the nursing homes and at risk populations.

IMHO opening as much as possible while also maintaining Hospital capacity is the course of action to take which is what many of the states like FL, GA, TX, TN, AR, SD to name a few are trying to do.

More of a controlled burn than a full-on burn.

Agree we may never see a vaccine and less fear is overdue.

Jacques Strap said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

This may be splitting hairs but IMHO we are not in full on burn through. Some states like CA remain fairly locked down while others like Florida and Georgia are more open and may be closer to full on burn mode. although hey retain some lockdown rules. Most are taking additional steps trying to protect the nursing homes and at risk populations.

IMHO opening as much as possible while also maintaining Hospital capacity is the course of action to take which is what many of the states like FL, GA, TX, TN, AR, SD to name a few are trying to do.

More of a controlled burn than a full-on burn.

Agree we may never see a vaccine and less fear is overdue.

---

Agree with Atl & Jacque. This virus will be with us for a while. We have to live with it.

Any vaccine will have similar effect as flu vaccines; bolster the immune system so our cases are not as severe. This virus will mutate and vaccines will be effective against the virus as it existed before the mutation.

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

What you and others are advocating is a prolonging of the inevitable under the false and/or unrealistic hope that we will find some medical panacea.

Jacques Strap said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

This may be splitting hairs but IMHO we are not in full on burn through. Some states like CA remain fairly locked down while others like Florida and Georgia are more open and may be closer to full on burn mode. although hey retain some lockdown rules. Most are taking additional steps trying to protect the nursing homes and at risk populations.

IMHO opening as much as possible while also maintaining Hospital capacity is the course of action to take which is what many of the states like FL, GA, TX, TN, AR, SD to name a few are trying to do.

More of a controlled burn than a full-on burn.

Agree we may never see a vaccine and less fear is overdue.

---

I agree. We are in control burn in some places and slow burn in others. We need to stop associating death and long term heath difficulties with something that statistically shows very little of either.

Meantime in New York City. This is historic. Things have changed and it will be a long time coming back.

Quote:

---

https://www.nytimes.com/2020/08/11/nyregion/nyc-economy-chain-stores.html?referringSource=articleShare

Retail Chains Abandon Manhattan: 'It's Unsustainable'
Some national chains, both retail and restaurants, are closing outlets in New York City, which are struggling more than their branches elsewhere.

For years, Bryant Park Grill & Cafe in Midtown Manhattan has been one of the country's top-grossing restaurants, the star property in Ark Restaurants' portfolio of 20 restaurants across the United States.
But what propelled it to the top has vanished.
The tourists are gone, the office towers surrounding it are largely empty and the restaurant's 1,000-seat dining room is closed. Instead, dinner is cooked and served on its patio, and the scaled-down restaurant brings in about $12,000 a day an 85 percent plunge in revenue, its chief executive said.
Five months into the pandemic, the drastic turn of events at businesses like Bryant Park Grill & Cafe that are part of national chains shows how the economic damage in New York has in many cases been far worse than elsewhere in the country.
In the heart of Manhattan, national chains including J.C. Penney, Kate Spade, Subway and Le Pain Quotidien have shuttered branches for good. Many other large brands, like Victoria's Secret and the Gap, have their kept high-profile locations closed in Manhattan, while reopening in other states.
Michael Weinstein, the chief executive of Ark Restaurants, who owns Bryant Park Grill & Cafe and 19 other restaurants, said he will never open another restaurant in New York.

A Uniqlo store on Fifth Avenue. Many businesses in Manhattan are struggling because of a lack of tourists and a relatively small number of office workers.
Of Ark Restaurants' five Manhattan restaurants, only two have reopened, while its properties in Florida where the virus is far worse have expanded outdoor seating with tents and tables into their parking lots, serving almost as many guests as they had indoors.
"There's no reason to do business in New York," Mr. Weinstein said. "I can do the same volume in Florida in the same square feet as I would have in New York, with my expenses being much less. The idea was that branding and locations were important, but the expense of being in this city has overtaken the marketing group that says you have to be there."
Even as the city has contained the virus and slowly reopens, there are ominous signs that some national brands are starting to abandon New York. The city is home to many flagship stores, chains and high-profile restaurants that tolerated astronomical rents and other costs because of New York's global cachet and the reliable onslaught of tourists and commuters.
But New York today looks nothing like it did just a few months ago.
In Manhattan's major retail corridors, from SoHo to Fifth Avenue to Madison Avenue, once packed sidewalks are now nearly empty. A fraction of the usual army of office workers goes into work every day, and many wealthy residents have left the city for second homes.

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

---

There's absolutely no basis for this claim, except that it happens to serve the burn-through agenda. The vaccine was never tested because there was no funding. The SARS scare was over, and investors lost interest. They can't flip a switch and produce immediate results just because we're ready for them now.

Let's see

What political party leads NYC?

Oh, democrats again

Makes sense

Carry on

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

---

There's absolutely no basis for this claim, except that it happens to serve the burn-through agenda. The vaccine was never tested because there was no funding. The SARS scare was over, and investors lost interest. They can't flip a switch and produce immediate results just because we're ready for them now.

---

If it had efficacy as a SARS vaccine they would have spun it up now. It did not.

Sam Lowry said:

---

ATL Bear said:

---

Jacques Strap said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

This may be splitting hairs but IMHO we are not in full on burn through. Some states like CA remain fairly locked down while others like Florida and Georgia are more open and may be closer to full on burn mode. although hey retain some lockdown rules. Most are taking additional steps trying to protect the nursing homes and at risk populations.

IMHO opening as much as possible while also maintaining Hospital capacity is the course of action to take which is what many of the states like FL, GA, TX, TN, AR, SD to name a few are trying to do.

More of a controlled burn than a full-on burn.

Agree we may never see a vaccine and less fear is overdue.

---

I agree. We are in control burn in some places and slow burn in others. We need to stop associating death and long term heath difficulties with something that statistically shows very little of either.

---

Actual statistics say otherwise. Excess deaths are way up, and I don't think it's all from sports withdrawal syndrome.

---

Excess deaths compared to what year and why?

Oldbear83 said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Jacques Strap said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

This may be splitting hairs but IMHO we are not in full on burn through. Some states like CA remain fairly locked down while others like Florida and Georgia are more open and may be closer to full on burn mode. although hey retain some lockdown rules. Most are taking additional steps trying to protect the nursing homes and at risk populations.

IMHO opening as much as possible while also maintaining Hospital capacity is the course of action to take which is what many of the states like FL, GA, TX, TN, AR, SD to name a few are trying to do.

More of a controlled burn than a full-on burn.

Agree we may never see a vaccine and less fear is overdue.

---

I agree. We are in control burn in some places and slow burn in others. We need to stop associating death and long term heath difficulties with something that statistically shows very little of either.

---

Actual statistics say otherwise. Excess deaths are way up, and I don't think it's all from sports withdrawal syndrome.

---

Excess deaths compared to what year and why?

---

Some folks have gotten so used to hysteria, they won't let go of it for anything.

"Actual statistics" say many things, depending on how they are analyzed and interpreted.

The media sees no reason to promote the good news, and they damn well hype the bad news, even if they have to make it up.

---

Absolutely true. And that is the consumers' fault. That is what sells.

Enemy of the people, at peoples' behest

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

---

There's absolutely no basis for this claim, except that it happens to serve the burn-through agenda. The vaccine was never tested because there was no funding. The SARS scare was over, and investors lost interest. They can't flip a switch and produce immediate results just because we're ready for them now.

---

If it had efficacy as a SARS vaccine they would have spun it up now. It did not.

---

According to whom?

Texas Medical Center
https://www.tmc.edu/coronavirus-updates/

Houston Methodist "COVID-19 Cases by Day". Click scroll to 2nd chart.
https://www.houstonmethodist.org/-/media/pdf/for-patients/Coronavirus/covid-19-stats.ashx

Death rates from coronavirus (COVID-19) in the United States (per 100,000 people)
https://www.statista.com/statistics/1109011/coronavirus-covid19-death-rates-us-by-state/
-- 08 12 2020 --
NJ 179
NY 169
FL 40
TX 32
CA 27

Total number of cases of coronavirus (COVID-19) in the United States by state
https://www.statista.com/statistics/1102807/coronavirus-covid19-cases-number-us-americans-by-state/
- 8-12-2020 --
CA 579k (39.5M population)
FL 543k (21.4M)
TX 518k (29M)
NY 422k (19.4M)
GA 223k (10.6M)

Daily confirmed COVID-19 cases and deaths, United States
https://ourworldindata.org/grapher/daily-covid-cases-deaths?time=2020-01-25..&country=~USA
-- 08 12 2020 -- New cases are down ~ 20,000 from the highs.

CDC Pneumonia Deaths and COVID-19 Deaths since 2/1/2020. Click for age group breakdown. Pneumonia more deadly for the young <24 years old, then it begins to even out.
https://data.cdc.gov/NCHS/Provisional-COVID-19-Death-Counts-by-Sex-Age-and-S/9bhg-hcku
-- 02/01/2020 to 08/01/2020 --
COVID-19 Deaths 142,164
Pneumonia Deaths 150,095

https://www.upi.com/Top_News/US/2020/08/12/US-reports-fewer-than-50K-new-COVID-19-cases-for-3rd-day-in-a-row/9481597226997/

U.S. reports fewer than 50K new COVID-19 cases for 3rd day in a row

Aug. 12 (UPI) -- For the third day in a row, new COVID-19 cases in the United States have totaled fewer than 50,000 -- the first time in more than a month that the daily national tally was under that mark for three days.

The case count Tuesday was 46,800, according to the Center for Systems Science and Engineering at Johns Hopkins University.

The United States averaged around 60,000 new cases per day during July.

The last time new U.S. cases were under 50,000 for three days was July 4-6.

Daily confirmed COVID-19 cases and deaths, United States
High day July 24 78,427
https://ourworldindata.org/grapher/daily-covid-cases-deaths?time=2020-01-25..&country=~USA

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

---

There's absolutely no basis for this claim, except that it happens to serve the burn-through agenda. The vaccine was never tested because there was no funding. The SARS scare was over, and investors lost interest. They can't flip a switch and produce immediate results just because we're ready for them now.

---

If it had efficacy as a SARS vaccine they would have spun it up now. It did not.

---

According to whom?

---

According to the Galveston National laboratory who hasn't moved forward or gotten any funding for it, but has and is working on other vaccine and research advances for Covid 19.

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

---

There's absolutely no basis for this claim, except that it happens to serve the burn-through agenda. The vaccine was never tested because there was no funding. The SARS scare was over, and investors lost interest. They can't flip a switch and produce immediate results just because we're ready for them now.

---

If it had efficacy as a SARS vaccine they would have spun it up now. It did not.

---

According to whom?

---

According to the Galveston National laboratory who hasn't moved forward or gotten any funding for it, but has and is working on other vaccine and research advances for Covid 19.

---

Source?

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

---

There's absolutely no basis for this claim, except that it happens to serve the burn-through agenda. The vaccine was never tested because there was no funding. The SARS scare was over, and investors lost interest. They can't flip a switch and produce immediate results just because we're ready for them now.

---

If it had efficacy as a SARS vaccine they would have spun it up now. It did not.

---

According to whom?

---

According to the Galveston National laboratory who hasn't moved forward or gotten any funding for it, but has and is working on other vaccine and research advances for Covid 19.

---

Source?

---

https://www.utmb.edu/gnl/news/2020/05/05/texas-monthly-inside-the-frantic-and-frustrating-race-to-develop-a-covid-19-vaccine-in-texas

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

---

There's absolutely no basis for this claim, except that it happens to serve the burn-through agenda. The vaccine was never tested because there was no funding. The SARS scare was over, and investors lost interest. They can't flip a switch and produce immediate results just because we're ready for them now.

---

If it had efficacy as a SARS vaccine they would have spun it up now. It did not.

---

According to whom?

---

According to the Galveston National laboratory who hasn't moved forward or gotten any funding for it, but has and is working on other vaccine and research advances for Covid 19.

---

Source?

---

https://www.utmb.edu/gnl/news/2020/05/05/texas-monthly-inside-the-frantic-and-frustrating-race-to-develop-a-covid-19-vaccine-in-texas

---

From your link:

Quote:

---

"As soon as we knew this was a coronavirus, we felt we had to jump at it," McLellan told UT News, "because we could be one of the first ones to get this structure. We knew exactly what mutations to put into this, because we've already shown these mutations work for a bunch of other coronaviruses."

His comments parallel those of Hotez and Bottazzi. As COVID-19 was racing through China in January, a research contact in that country confirmed to the team in Houston that the virus was more closely related to SARS than to MERS. As soon as scientists were able to identify the new coronavirus's genetic code, Bottazzi and Hotez began to explore the similarities between it and the SARS virus in closer detail. What they've discovered, they said, is promising.

Not only do the two viruses exhibit similar genetic codes and bind to the same receptors on human cells, new lab experiments appear to show that the blood of patients infected by SARS in 2003 can neutralize the virus that causes COVID-19, meaning some people may have an inherent immunity.

"That's when the little light bulb turned on," Bottazzi said. "We realized that they're so similar that maybe our vaccine is something that can be repurposed for this new outbreak. Even though it may not be the perfect vaccine, it's certainly sufficiently similar that it will provide some added value in reducing the severity of the disease.

For all the good work being done, researchers like Bottazzi and Weaver caution that there is no quick fix for the new coronavirus. Even the most sanguine forecasts - those that assume unpredictable human trials will proceed without a hitch - do not predict a widely used vaccine for the public until well into 2021, at the earliest.

That's simply how long it takes to develop and test a vaccine, to ensure that it's not only effective but safe, in the general population and for groups of patients with specific characteristics. But it's also a reminder of the importance of funding research with uncertain tangible results in times when there's no imminent crisis. The neglect of Hotez and Bottazzi's SARS vaccine is an example of what can happen when research funding freezes up. When funding continues, so can progress. Three years ago, using a technology developed by microbiologist John Schoggins, of UT - Southwestern Medical Center, in Dallas, researchers began a study that identified a protein produced by the human immune system that can inhibit coronaviruses, including SARS and MERS. With the benefit of multiple grants, Schoggins and his international partners continued their work and determined this February that the same protein inhibits the COVID-19 virus. Any potential for developing this knowledge into a treatment remains years off - but it's years closer than it would have been without continued funding.

Hotez and Bottazzi are hopeful that their vaccine will be tested in clinical trials soon. Once they get funding in place, they said, they could begin testing their vaccine in clinical trials on Texans infected with COVID-19 in as little as six weeks, possibly sooner. The idea that just $3 million - a sum of money amounting to a modest NBA contract - is all that stands in the way is simply too absurd for them to consider it insurmountable. "I'm upbeat because, you know, if I focused on my frustration, I could just sit down and cry," said Bottazzi, forcing a smile twelve hours into a day that began, like so many recently, with buzzing text messages from researchers around the world at 3 a.m. "I mean, the frustration is invigorating us to do a hundred thousand things at the same time."

As we spoke, Hotez's iPhone began buzzing. On the line: a reporter from 60 Minutes. Normally a great opportunity, as far as interviews spotlighting academic work are concerned, but not the audience the researchers were truly seeking. Who they really wanted to talk to, they said, was somebody in the federal government with the power to fast-track the testing of their vaccine.

Even now, when everything is going crazy and we should have all the resources at our command to move this forward, we're still getting these emails that say, 'Here's a request for applications,'" Hotez said, referring to government agencies that have asked his team to apply for grant money, a process that would take months at best.

Navigating America's sprawling, regulation-clogged public health infrastructure is a familiar challenge to researchers, of course. Hotez has recently become more strident in his public remarks. When he testified before the House Committee on Science, Space, and Technology on March 5, he said that by failing to fund vaccine development when the private sector wouldn't, the government had missed a major opportunity to avoid a health crisis. "It's tragic that we won't have a vaccine ready for this epidemic," Hotez said then. "Practically speaking, we'll be fighting these outbreaks with one hand tied behind our backs."

In the meantime, he and Bottazzi have pivoted to soliciting the investment they need from regional philanthropists. Bottazzi, who was born in Italy but has spent thirty years in Texas, has shaped her appeal around a theme that Texans are uniquely receptive to: bragging rights. "It would be fantastic to say that Houston has one of the first vaccines [for COVID19] being evaluated," she said. "How could that not resonate?"

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

---

There's absolutely no basis for this claim, except that it happens to serve the burn-through agenda. The vaccine was never tested because there was no funding. The SARS scare was over, and investors lost interest. They can't flip a switch and produce immediate results just because we're ready for them now.

---

If it had efficacy as a SARS vaccine they would have spun it up now. It did not.

---

According to whom?

---

According to the Galveston National laboratory who hasn't moved forward or gotten any funding for it, but has and is working on other vaccine and research advances for Covid 19.

---

Source?

---

https://www.utmb.edu/gnl/news/2020/05/05/texas-monthly-inside-the-frantic-and-frustrating-race-to-develop-a-covid-19-vaccine-in-texas

---

From your link:

Quote:

---

"As soon as we knew this was a coronavirus, we felt we had to jump at it," McLellan told UT News, "because we could be one of the first ones to get this structure. We knew exactly what mutations to put into this, because we've already shown these mutations work for a bunch of other coronaviruses."

His comments parallel those of Hotez and Bottazzi. As COVID-19 was racing through China in January, a research contact in that country confirmed to the team in Houston that the virus was more closely related to SARS than to MERS. As soon as scientists were able to identify the new coronavirus's genetic code, Bottazzi and Hotez began to explore the similarities between it and the SARS virus in closer detail. What they've discovered, they said, is promising.

Not only do the two viruses exhibit similar genetic codes and bind to the same receptors on human cells, new lab experiments appear to show that the blood of patients infected by SARS in 2003 can neutralize the virus that causes COVID-19, meaning some people may have an inherent immunity.

"That's when the little light bulb turned on," Bottazzi said. "We realized that they're so similar that maybe our vaccine is something that can be repurposed for this new outbreak. Even though it may not be the perfect vaccine, it's certainly sufficiently similar that it will provide some added value in reducing the severity of the disease.

For all the good work being done, researchers like Bottazzi and Weaver caution that there is no quick fix for the new coronavirus. Even the most sanguine forecasts - those that assume unpredictable human trials will proceed without a hitch - do not predict a widely used vaccine for the public until well into 2021, at the earliest.

That's simply how long it takes to develop and test a vaccine, to ensure that it's not only effective but safe, in the general population and for groups of patients with specific characteristics. But it's also a reminder of the importance of funding research with uncertain tangible results in times when there's no imminent crisis. The neglect of Hotez and Bottazzi's SARS vaccine is an example of what can happen when research funding freezes up. When funding continues, so can progress. Three years ago, using a technology developed by microbiologist John Schoggins, of UT - Southwestern Medical Center, in Dallas, researchers began a study that identified a protein produced by the human immune system that can inhibit coronaviruses, including SARS and MERS. With the benefit of multiple grants, Schoggins and his international partners continued their work and determined this February that the same protein inhibits the COVID-19 virus. Any potential for developing this knowledge into a treatment remains years off - but it's years closer than it would have been without continued funding.

Hotez and Bottazzi are hopeful that their vaccine will be tested in clinical trials soon. Once they get funding in place, they said, they could begin testing their vaccine in clinical trials on Texans infected with COVID-19 in as little as six weeks, possibly sooner. The idea that just $3 million - a sum of money amounting to a modest NBA contract - is all that stands in the way is simply too absurd for them to consider it insurmountable. "I'm upbeat because, you know, if I focused on my frustration, I could just sit down and cry," said Bottazzi, forcing a smile twelve hours into a day that began, like so many recently, with buzzing text messages from researchers around the world at 3 a.m. "I mean, the frustration is invigorating us to do a hundred thousand things at the same time."

As we spoke, Hotez's iPhone began buzzing. On the line: a reporter from 60 Minutes. Normally a great opportunity, as far as interviews spotlighting academic work are concerned, but not the audience the researchers were truly seeking. Who they really wanted to talk to, they said, was somebody in the federal government with the power to fast-track the testing of their vaccine.

Even now, when everything is going crazy and we should have all the resources at our command to move this forward, we're still getting these emails that say, 'Here's a request for applications,'" Hotez said, referring to government agencies that have asked his team to apply for grant money, a process that would take months at best.

Navigating America's sprawling, regulation-clogged public health infrastructure is a familiar challenge to researchers, of course. Hotez has recently become more strident in his public remarks. When he testified before the House Committee on Science, Space, and Technology on March 5, he said that by failing to fund vaccine development when the private sector wouldn't, the government had missed a major opportunity to avoid a health crisis. "It's tragic that we won't have a vaccine ready for this epidemic," Hotez said then. "Practically speaking, we'll be fighting these outbreaks with one hand tied behind our backs."

In the meantime, he and Bottazzi have pivoted to soliciting the investment they need from regional philanthropists. Bottazzi, who was born in Italy but has spent thirty years in Texas, has shaped her appeal around a theme that Texans are uniquely receptive to: bragging rights. "It would be fantastic to say that Houston has one of the first vaccines [for COVID19] being evaluated," she said. "How could that not resonate?"

---

---

Yes, they're promoting their prior work so they can get funding. No one's biting. That's the tell tale, not that scientists who spent years on something no one is jumping on, even now when everyone's looking to find a vaccine, and is all you need to know.

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

---

There's absolutely no basis for this claim, except that it happens to serve the burn-through agenda. The vaccine was never tested because there was no funding. The SARS scare was over, and investors lost interest. They can't flip a switch and produce immediate results just because we're ready for them now.

---

If it had efficacy as a SARS vaccine they would have spun it up now. It did not.

---

According to whom?

---

According to the Galveston National laboratory who hasn't moved forward or gotten any funding for it, but has and is working on other vaccine and research advances for Covid 19.

---

Source?

---

https://www.utmb.edu/gnl/news/2020/05/05/texas-monthly-inside-the-frantic-and-frustrating-race-to-develop-a-covid-19-vaccine-in-texas

---

From your link:

Quote:

---

"As soon as we knew this was a coronavirus, we felt we had to jump at it," McLellan told UT News, "because we could be one of the first ones to get this structure. We knew exactly what mutations to put into this, because we've already shown these mutations work for a bunch of other coronaviruses."

His comments parallel those of Hotez and Bottazzi. As COVID-19 was racing through China in January, a research contact in that country confirmed to the team in Houston that the virus was more closely related to SARS than to MERS. As soon as scientists were able to identify the new coronavirus's genetic code, Bottazzi and Hotez began to explore the similarities between it and the SARS virus in closer detail. What they've discovered, they said, is promising.

Not only do the two viruses exhibit similar genetic codes and bind to the same receptors on human cells, new lab experiments appear to show that the blood of patients infected by SARS in 2003 can neutralize the virus that causes COVID-19, meaning some people may have an inherent immunity.

"That's when the little light bulb turned on," Bottazzi said. "We realized that they're so similar that maybe our vaccine is something that can be repurposed for this new outbreak. Even though it may not be the perfect vaccine, it's certainly sufficiently similar that it will provide some added value in reducing the severity of the disease.

For all the good work being done, researchers like Bottazzi and Weaver caution that there is no quick fix for the new coronavirus. Even the most sanguine forecasts - those that assume unpredictable human trials will proceed without a hitch - do not predict a widely used vaccine for the public until well into 2021, at the earliest.

That's simply how long it takes to develop and test a vaccine, to ensure that it's not only effective but safe, in the general population and for groups of patients with specific characteristics. But it's also a reminder of the importance of funding research with uncertain tangible results in times when there's no imminent crisis. The neglect of Hotez and Bottazzi's SARS vaccine is an example of what can happen when research funding freezes up. When funding continues, so can progress. Three years ago, using a technology developed by microbiologist John Schoggins, of UT - Southwestern Medical Center, in Dallas, researchers began a study that identified a protein produced by the human immune system that can inhibit coronaviruses, including SARS and MERS. With the benefit of multiple grants, Schoggins and his international partners continued their work and determined this February that the same protein inhibits the COVID-19 virus. Any potential for developing this knowledge into a treatment remains years off - but it's years closer than it would have been without continued funding.

Hotez and Bottazzi are hopeful that their vaccine will be tested in clinical trials soon. Once they get funding in place, they said, they could begin testing their vaccine in clinical trials on Texans infected with COVID-19 in as little as six weeks, possibly sooner. The idea that just $3 million - a sum of money amounting to a modest NBA contract - is all that stands in the way is simply too absurd for them to consider it insurmountable. "I'm upbeat because, you know, if I focused on my frustration, I could just sit down and cry," said Bottazzi, forcing a smile twelve hours into a day that began, like so many recently, with buzzing text messages from researchers around the world at 3 a.m. "I mean, the frustration is invigorating us to do a hundred thousand things at the same time."

As we spoke, Hotez's iPhone began buzzing. On the line: a reporter from 60 Minutes. Normally a great opportunity, as far as interviews spotlighting academic work are concerned, but not the audience the researchers were truly seeking. Who they really wanted to talk to, they said, was somebody in the federal government with the power to fast-track the testing of their vaccine.

Even now, when everything is going crazy and we should have all the resources at our command to move this forward, we're still getting these emails that say, 'Here's a request for applications,'" Hotez said, referring to government agencies that have asked his team to apply for grant money, a process that would take months at best.

Navigating America's sprawling, regulation-clogged public health infrastructure is a familiar challenge to researchers, of course. Hotez has recently become more strident in his public remarks. When he testified before the House Committee on Science, Space, and Technology on March 5, he said that by failing to fund vaccine development when the private sector wouldn't, the government had missed a major opportunity to avoid a health crisis. "It's tragic that we won't have a vaccine ready for this epidemic," Hotez said then. "Practically speaking, we'll be fighting these outbreaks with one hand tied behind our backs."

In the meantime, he and Bottazzi have pivoted to soliciting the investment they need from regional philanthropists. Bottazzi, who was born in Italy but has spent thirty years in Texas, has shaped her appeal around a theme that Texans are uniquely receptive to: bragging rights. "It would be fantastic to say that Houston has one of the first vaccines [for COVID19] being evaluated," she said. "How could that not resonate?"

---

---

Yes, they're promoting their prior work so they can get funding. No one's biting. That's the tell tale, not that scientists who spent years on something no one is jumping on, even now when everyone's looking to find a vaccine, and is all you need to know.

---

What you're saying isn't according to the laboratory's position. It's directly contrary to it:

Quote:

---

Dr. James LeDuc, director of the Galveston National Laboratory, said work has resumed on the SARS vaccine that his researchers helped develop with Hotez's team. The laboratory, a high-security biocontainment facility on Texas' Gulf Coast, received a live sample of the new coronavirus last month and will use it to test the vaccine in mice.

But first the lab must breed a colony of mice genetically engineered to replicate the human disease, a process that LeDuc said will take months.

"I think we as a nation and as a society need to be more agile in recognizing that new diseases do occur, and once they've cropped up, they very well may come again, maybe not the same but very similar," said LeDuc, who formerly directed influenza response efforts at the Centers for Disease Control and Prevention. "So it was a shame that we had to stop that work and now are having to try and restart it."

For weeks, Hotez has been reaching out to pharmaceutical companies and federal scientific agencies and even the Medical Research Council in the United Kingdom asking them to provide the roughly $3 million needed to begin testing the vaccine's safety in humans, but so far none have done so.

"We've had some conversations with big pharma companies in recent weeks about our vaccine, and literally one said, 'Well, we're holding back to see if this thing comes back year after year,'" Hotez said.

https://www.nbcnews.com/health/health-care/scientists-were-close-coronavirus-vaccine-years-ago-then-money-dried-n1150091

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

Sam Lowry said:

---

ATL Bear said:

---

We're in full on burn through, so embrace it. No magic science is around the corner to save us. There has never been a coronavirus vaccine for any strain. We will continue to get better at symptom treatment, but that's it, and is why deaths have decoupled from case growth.

I'm sure someone will come up with some half measure immune booster that shows limited prevention, sort of like the flu vaccine, but our best weapon will be our own natural boosting of our defense through T cell immune responses. A little courage and less fear is way over due.

---

Scientists know we're looking for the least bad of many bad outcomes. There's no magical thinking involved. Flu vaccines are effective. We were close to a vaccine for SARS-1 when the epidemic died down and people lost interest. We're paying the price for it now. If we pay a higher price next time (and there will be a next time), it will be because of attitudes like this. What's overdue is a little longer attention span and a little more concern for something besides the next football season.

---

The vaccine from SARS1 was only claimed to be effective. It never got to trials. If it were that close and/or effective, it would already be spun up now. But it isn't.

---

There's absolutely no basis for this claim, except that it happens to serve the burn-through agenda. The vaccine was never tested because there was no funding. The SARS scare was over, and investors lost interest. They can't flip a switch and produce immediate results just because we're ready for them now.

---

If it had efficacy as a SARS vaccine they would have spun it up now. It did not.

---

According to whom?

---

According to the Galveston National laboratory who hasn't moved forward or gotten any funding for it, but has and is working on other vaccine and research advances for Covid 19.

---

Source?

---

https://www.utmb.edu/gnl/news/2020/05/05/texas-monthly-inside-the-frantic-and-frustrating-race-to-develop-a-covid-19-vaccine-in-texas

---

From your link:

Quote:

---

"As soon as we knew this was a coronavirus, we felt we had to jump at it," McLellan told UT News, "because we could be one of the first ones to get this structure. We knew exactly what mutations to put into this, because we've already shown these mutations work for a bunch of other coronaviruses."

His comments parallel those of Hotez and Bottazzi. As COVID-19 was racing through China in January, a research contact in that country confirmed to the team in Houston that the virus was more closely related to SARS than to MERS. As soon as scientists were able to identify the new coronavirus's genetic code, Bottazzi and Hotez began to explore the similarities between it and the SARS virus in closer detail. What they've discovered, they said, is promising.

Not only do the two viruses exhibit similar genetic codes and bind to the same receptors on human cells, new lab experiments appear to show that the blood of patients infected by SARS in 2003 can neutralize the virus that causes COVID-19, meaning some people may have an inherent immunity.

"That's when the little light bulb turned on," Bottazzi said. "We realized that they're so similar that maybe our vaccine is something that can be repurposed for this new outbreak. Even though it may not be the perfect vaccine, it's certainly sufficiently similar that it will provide some added value in reducing the severity of the disease.

For all the good work being done, researchers like Bottazzi and Weaver caution that there is no quick fix for the new coronavirus. Even the most sanguine forecasts - those that assume unpredictable human trials will proceed without a hitch - do not predict a widely used vaccine for the public until well into 2021, at the earliest.

That's simply how long it takes to develop and test a vaccine, to ensure that it's not only effective but safe, in the general population and for groups of patients with specific characteristics. But it's also a reminder of the importance of funding research with uncertain tangible results in times when there's no imminent crisis. The neglect of Hotez and Bottazzi's SARS vaccine is an example of what can happen when research funding freezes up. When funding continues, so can progress. Three years ago, using a technology developed by microbiologist John Schoggins, of UT - Southwestern Medical Center, in Dallas, researchers began a study that identified a protein produced by the human immune system that can inhibit coronaviruses, including SARS and MERS. With the benefit of multiple grants, Schoggins and his international partners continued their work and determined this February that the same protein inhibits the COVID-19 virus. Any potential for developing this knowledge into a treatment remains years off - but it's years closer than it would have been without continued funding.

Hotez and Bottazzi are hopeful that their vaccine will be tested in clinical trials soon. Once they get funding in place, they said, they could begin testing their vaccine in clinical trials on Texans infected with COVID-19 in as little as six weeks, possibly sooner. The idea that just $3 million - a sum of money amounting to a modest NBA contract - is all that stands in the way is simply too absurd for them to consider it insurmountable. "I'm upbeat because, you know, if I focused on my frustration, I could just sit down and cry," said Bottazzi, forcing a smile twelve hours into a day that began, like so many recently, with buzzing text messages from researchers around the world at 3 a.m. "I mean, the frustration is invigorating us to do a hundred thousand things at the same time."

As we spoke, Hotez's iPhone began buzzing. On the line: a reporter from 60 Minutes. Normally a great opportunity, as far as interviews spotlighting academic work are concerned, but not the audience the researchers were truly seeking. Who they really wanted to talk to, they said, was somebody in the federal government with the power to fast-track the testing of their vaccine.

Even now, when everything is going crazy and we should have all the resources at our command to move this forward, we're still getting these emails that say, 'Here's a request for applications,'" Hotez said, referring to government agencies that have asked his team to apply for grant money, a process that would take months at best.

Navigating America's sprawling, regulation-clogged public health infrastructure is a familiar challenge to researchers, of course. Hotez has recently become more strident in his public remarks. When he testified before the House Committee on Science, Space, and Technology on March 5, he said that by failing to fund vaccine development when the private sector wouldn't, the government had missed a major opportunity to avoid a health crisis. "It's tragic that we won't have a vaccine ready for this epidemic," Hotez said then. "Practically speaking, we'll be fighting these outbreaks with one hand tied behind our backs."

In the meantime, he and Bottazzi have pivoted to soliciting the investment they need from regional philanthropists. Bottazzi, who was born in Italy but has spent thirty years in Texas, has shaped her appeal around a theme that Texans are uniquely receptive to: bragging rights. "It would be fantastic to say that Houston has one of the first vaccines [for COVID19] being evaluated," she said. "How could that not resonate?"

---

---

Yes, they're promoting their prior work so they can get funding. No one's biting. That's the tell tale, not that scientists who spent years on something no one is jumping on, even now when everyone's looking to find a vaccine, and is all you need to know.

---

What you're saying isn't according to the laboratory's position. It's directly contrary to it:

Quote:

---

Dr. James LeDuc, director of the Galveston National Laboratory, said work has resumed on the SARS vaccine that his researchers helped develop with Hotez's team. The laboratory, a high-security biocontainment facility on Texas' Gulf Coast, received a live sample of the new coronavirus last month and will use it to test the vaccine in mice.

But first the lab must breed a colony of mice genetically engineered to replicate the human disease, a process that LeDuc said will take months.

"I think we as a nation and as a society need to be more agile in recognizing that new diseases do occur, and once they've cropped up, they very well may come again, maybe not the same but very similar," said LeDuc, who formerly directed influenza response efforts at the Centers for Disease Control and Prevention. "So it was a shame that we had to stop that work and now are having to try and restart it."

For weeks, Hotez has been reaching out to pharmaceutical companies and federal scientific agencies and even the Medical Research Council in the United Kingdom asking them to provide the roughly $3 million needed to begin testing the vaccine's safety in humans, but so far none have done so.

"We've had some conversations with big pharma companies in recent weeks about our vaccine, and literally one said, 'Well, we're holding back to see if this thing comes back year after year,'" Hotez said.

https://www.nbcnews.com/health/health-care/scientists-were-close-coronavirus-vaccine-years-ago-then-money-dried-n1150091

---

---

You aren't grasping what's actually happening. Billions are being thrown around to find a vaccine. This lab is griping because they can't get $3 million to start up what they say has promise from work done years ago. If it had promise it would get the funding. In fact I don't even know what we're debating at this point. If this particular vaccine had any promise it would be being worked on. It's not. There is other science out of this lab that is getting funding and being worked on to see if it can be a potential Covid vaccine.

Is Europe moving into a phase where they and focus on not overwhelming hospitals and protecting the at risk?

Will they move back to hard lockdowns of everyone and remain there for unknown amount of time until a safe effective vaccine appears?

Some of the states such as FL TX GA TN etc. seem to have found a balance between softer lockdowns while still maintain hospital capacity. I wonder if that is where Europe is headed.


https://www.bbc.com/news/world-europe-53747852

Germany has recorded its biggest daily increase in coronavirus cases in more than three months as European countries struggle to curb a surge in infections.

Meanwhile, France had 2,524 new cases in 24 hours, the highest daily rise since its lockdown was lifted in May.

Spain is facing the worst coronavirus infection rate in Western Europe. It recorded 1,418 new infections in its latest daily count on Tuesday and said there were 675 "active outbreaks" in the country.

IDK how you can say New Zealand "Beat the Virus". If they are fighting it they haven't beat it. They may have delayed the inevitable spread, but how long can you stay in "go hard" mode waiting for a vaccine that may turn out to only be as efficacious as the annual flu shot? Would countries have locked down from the get go if they had known it was a 0.24% fatality rate?

https://www.nytimes.com/2020/08/13/world/asia/new-zealand-coronavirus-lockdown-elimination.html

Quote:

---

New Zealand Beat the Virus Once. Can It Do It Again?

Prime Minister Jacinda Ardern has revived her "go hard, go early" approach as officials grapple with a mysterious cluster that might have originated in a frozen food warehouse.

Jeremy Hutton, 28, who works in finance and was out for a walk and a take-away coffee on Thursday morning, asked what seemed to be on the minds of many: "Are we just going to keep doing this every couple of months?"

---

Jacques Strap said:

---

Is Europe moving into a phase where they and focus on not overwhelming hospitals and protecting the at risk?

Will they move back to hard lockdowns of everyone and remain there for unknown amount of time until a safe effective vaccine appears?

Some of the states such as FL TX GA TN etc. seem to have found a balance between softer lockdowns while still maintain hospital capacity. I wonder if that is where Europe is headed.


https://www.bbc.com/news/world-europe-53747852

Germany has recorded its biggest daily increase in coronavirus cases in more than three months as European countries struggle to curb a surge in infections.

Meanwhile, France had 2,524 new cases in 24 hours, the highest daily rise since its lockdown was lifted in May.

Spain is facing the worst coronavirus infection rate in Western Europe. It recorded 1,418 new infections in its latest daily count on Tuesday and said there were 675 "active outbreaks" in the country.

---

Sweden reached is lowest daily death rates since March.

Jacques Strap said:

---

Some of the states such as FL TX GA TN etc. seem to have found a balance between softer lockdowns while still maintain hospital capacity. I wonder if that is where Europe is headed.

---

I agree with this. Restaurants and retailers in Tx have hope. They're open, even if only partially..

I believe there will be a surge of cases when schools open. We'll see how these cases are managed.